Table 4.
Training | Validation | ||||||
---|---|---|---|---|---|---|---|
Group | Total | Death | Actual survival rate | Group | Total | Death | Actual survival rate |
HR | 99 | 1 | 99% | HR | 118 | 1 | 99% |
HER2+ | 33 | 1 | 97% | HER2+ | 45 | 1 | 98% |
TN | 11 | 0 | 100% | TN | 13 | 0 | 100% |
HR, hormone receptor positive; HER2+, human epidermal growth factor 2 positive; TN, triple-negative breast cancer. This indicates that the prediction results of the prediction model match the actual results with high agreement.